Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003

Competition and co-operation of PARP-1 and DNA-PK in the repair of DNA strand breaks

S. Veuger, N. Curtin, A. Calvert, D. Newell, R. Griffin, G. Smith, Z. Hostomsky, B. Durkacz

Med Sci Monit 2003; 9(1): 74-0 :: ID: 15217


Cells deficient in poly(ADP-ribose) polymerase (PARP-1) or DNA-dependent protein kinase (DNA-PK) are highly radiosensitive. Potent, specific inhibitors of PARP-1 (AG14361) and DNA-PK (NU7026) developed in collaboration with KuDOS Pharmaceuticals (UK) and Agouron/Pfizer GRD (CA), respectively, are radiosensitizers when used alone and in combination [1]. To fully exploit the potential of PARP-1 and DNA-PK inhibitors for cancer therapy, a mechanistic understanding of their interactions is essential. Reciprocal regulation by the two enzymes, and the effects of AG14361 and NU7026, were investigated using both purified enzyme assays and a permeabilised cell system. A 30 bp double stranded oligonucleotide was used to stimulate the activity of the enzymes. PARP-1 activity was not affected by the presence of DNA-PK, nor was DNA-PK activity affected by PARP-1 provided the substrates ATP and NAD were present. However, in the absence of ATP or the presence of NU7026, DNA-PK inhibited PARP-1 activity by 25% and 50% respectively. In the absence of NAD or the presence of AG14361, PARP-1 inhibited DNA-PK activity by 75%.Very similar results were obtained using the inhibitors in permeabilised cells either proficient or deficient in PARP-1 or DNA-PK. Ionizing radiation-induced DNA double strand break (DSB) repair in these cell lines was inhibited by both inhibitors and reduced DSB repair was also seen in the deficient cell lines. These data suggest that both PARP-1 and DNA-PK bind to DNA ends and co-operate in DSB repair. References: 1.Veuger SJ, Curtin NJ, Golding BT et al: Radiosensitisation and modulation of DNA repair by novel inhibitors of PARP and DNA-PK in vitro. Proc Am Assoc Cancer Res, 2002; 43: 4142

Keywords: PARP-1, DNA-PK, DNA Repair

Add Comment 0 Comments


01 July 2024 : Editorial  

Editorial: The Global Threats of Increasing Antimicrobial Resistance Require New Approaches to Drug Development, Including Molecular Antimicrobial Adjuvants

Dinah V. Parums

DOI: 10.12659/MSM.945583

Med Sci Monit 2024; 30:e945583


In Press

Clinical Research  

Ultrasound-Guided PRP and SVF Therapy Shows Sustained Improvement in Severe Knee Osteoarthritis: A 12-Month...

Med Sci Monit In Press; DOI: 10.12659/MSM.943975  

Clinical Research  

Olfactory Dysfunction as a Marker for Cognitive Impairment in General Paresis of the Insane: A Clinical Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944243  

Clinical Research  

Endoscopic and Microscopic Tympanoplasty for Adhesive Otitis Media: A Comparative Prospective Analysis

Med Sci Monit In Press; DOI: 10.12659/MSM.945152  

Clinical Research  

Status of Professional Identity, Self-Directed Learning Competence, and Self-Efficacy Among Central Sterile...

Med Sci Monit In Press; DOI: 10.12659/MSM.944044  

Most Viewed Current Articles

17 Jan 2024 : Review article   4,462,997

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799


14 Dec 2022 : Clinical Research   1,599,717

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990


16 May 2023 : Clinical Research   691,092

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387


01 Jan 2022 : Editorial   50,889

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952


Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750